Clinical trial
Does VoltagE Guided Additional Ablation Improve Procedural Outcome of Atrial Fibrillation Ablation? (The VEGA-AF Study)
NCT03377751 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does VoltagE Guided Additional Ablation Improve Procedural Outcome of Atrial Fibrillation Ablation? (The VEGA-AF Study)
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 15, 2018
- Completion date
- December 15, 2019
- Enrollment
- 20 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.